Where EAEU pharma compliance draws the line on gifts and bribes
A pharma company’s compliance officer rarely catches a violation based on the receipt total alone. A box of chocolates well within the permissible threshold can turn out to be an instrument of influence over a procurement decision, while giving a physician free access to a specialized educational course remains a lawful element of partnership with the medical community. The price of a gift alone is a weak indicator of risk.
The real boundary lies in the giver’s intent and the expectation of a reciprocal action. As soon as handing over something of value is tied to anticipating a specific decision from the recipient, it stops being a gift from a legal standpoint, regardless of the amount. For companies operating across several Eurasian Economic Union (EAEU) countries, this line is further complicated by the fact that thresholds, prohibited categories of recipient, and fines do not align between Russia, Kazakhstan, and Belarus.
Why a Harmless Gift Functions as a Lever of Influence
The legal definition of a gift rests on gratuitousness: something of value is transferred with no reciprocal obligation, purely as a gesture of respect or appreciation. Psychological reality diverges from this definition. Robert Cialdini described the principle of reciprocity: receiving a service or item creates a subconscious sense of obligation in a person, even if the giver asked for nothing explicitly in return.
In a professional setting, this works through three channels at once:
Obligation. The recipient feels compelled to respond with an action whose significance may significantly exceed the monetary value of the gift.
Informal closeness. A personal bond forms between the parties, making it easier to decide in the giver’s favor.
Social pressure. Violating the unwritten norm of reciprocity is read by peers as ingratitude, which further nudges the recipient toward a return favor.
For the compliance function, the takeaway is simple: if the giver is counting on a preference, a shift in position, or an official’s loyalty, the gift effectively becomes an instrument of bribery, regardless of its market value. This is exactly why all three EAEU jurisdictions and international pharmaceutical associations build their rules around the giver’s motive and the recipient’s status. The gift’s price plays a secondary role in that logic.
Table 1. How the approach to gifts and bribery has changed
| Parameter | Before formalization | Current approach |
|---|---|---|
| Basis for interacting with a doctor or official | Personal arrangements, verbal promises | Written company policy, gift register |
| Test for permissibility | Subjective judgment («is this appropriate?») | A specific monetary limit per country |
| Liability for a partner’s conduct | Not addressed in the contract | Anti-corruption clause with termination rights |
| Disclosure | Not provided for | Public or aggregated reporting (AIPM, EFPIA) |
Russian Regulation, the 3,000-Ruble Limit and Special Rules for Healthcare
Article 575 of the Civil Code of the Russian Federation prohibits giving gifts to certain categories of people, with an exception for ordinary gifts worth no more than 3,000 rubles. The restriction covers employees of medical and educational organizations, people receiving treatment or care at such institutions, state and municipal civil servants, and Bank of Russia employees acting in connection with their official position.
The 3,000-ruble cap is not a blanket shield. If handing over a gift worth even 500 rubles comes with a request to take a specific action in the giver’s favor, the act is classified as bribery under Articles 290, 291 or 291.2 of the Criminal Code of the Russian Federation. Article 291.2 separately covers petty bribery involving amounts up to 10,000 rubles and carries a penalty of up to one year’s imprisonment, even where the sum involved is small. The line between a gift and a bribe rests on motive: a gift carries no reciprocal obligation, while a bribe is given specifically for an act or omission in the course of official duty.
The pharmaceutical market carries additional restrictions under Article 74 of Federal Law No. 323-FZ, «On the Fundamentals of Protecting the Health of Citizens in the Russian Federation» (hereinafter, Law No. 323-FZ). Healthcare workers and heads of medical organizations are barred from accepting gifts and money from drug manufacturers, marketing authorization holders, distributors, and pharmacy organizations, including payment for entertainment, leisure travel, and holiday travel. Taking part in entertainment events funded by companies and receiving drug samples to hand to patients outside clinical trials are likewise prohibited.
The exceptions are limited to formal agreements for clinical trials, clinical investigations of medical devices, and payment for teaching or research work. The same rule applies to pharmacy workers and heads of pharmacy organizations. In the summer of 2025, Federal Law No. 150-FZ expanded and spelled out the list of prohibited interactions with companies in more detail.
Companies that take part in state and municipal procurement under Laws No. 44-FZ and 223-FZ face the same principle, plus an additional category of risk. Members of the procuring entity’s tender commission are treated as officials for the purposes of Articles 290 and 291 of the Criminal Code. Any reward given to a commission member for winning a specific tender therefore qualifies as a bribe, whether it is structured as a gift, a consulting agreement, or a sponsorship contract.
Kazakhstan and Belarus, Two Different Paths to the Same Goal
Kazakhstani law is moving toward a strict regime for civil servants, though there is no blanket ban on gifts to this category. Article 509 of the Civil Code of the Republic of Kazakhstan allows customary gifts worth up to 10 Monthly Calculation Indices (MCI) even to officials, provided the gift is tied to a protocol event or holiday. An absolute ban applies only when the gift is linked to an official’s act or omission in favor of the giver.
Table 2. Limits and fines in Kazakhstan, 2025-2026
| Indicator | 2025 | 2026 |
|---|---|---|
| Value of 1 MCI | 3,932 KZT | 4,325 KZT |
| Customary gift limit (10 MCI) | 39,320 KZT | 43,250 KZT |
| Fine for an unlawful gift to an official (Art. 676, Administrative Code of the RK) | 200 MCI | 865,000 KZT |
A gift received by a civil servant without their knowledge, or in connection with the performance of their duties, must be handed over free of charge to the State Property and Privatization Committee under Kazakhstan’s Ministry of Finance within seven calendar days of receipt. The official may later buy the gift back at market value if they decline to pass it on to a third party. The mechanism genuinely operates: in 2022 and the first half of 2023 alone, officials turned in 438 gifts to the authorized body, some of which were later sold at auction.
The Belarusian model stands apart in that it extends restrictions beyond civil servants to executives of commercial organizations. Belarus’s Law No. 305-Z of 15 July 2015, «On Combating Corruption,» defines corruption as an official’s intentional use of their position to obtain a property benefit. Fines and thresholds are calculated against the base amount, which has stood at 45 Belarusian rubles since 1 January 2026, up from 42 rubles in 2025.
A separate point worth attention is the tax-free threshold for gifts from individuals who are not close relatives. In 2025, paragraph 22 of Article 208 of the Tax Code of the Republic of Belarus exempted such gifts from income tax up to 11,516 rubles per calendar year. Since 1 January 2026, that tax-free threshold has been cut by nearly half, to 6,000 rubles, with anything above it taxed at the standard 13% rate. Companies planning informal tokens of appreciation for partners in Belarus should rework their budgets around the new threshold rather than last year’s figure.
International Standards and Hospitality Limits
For companies with foreign ownership, the benchmark is set not only by local law but also by industry codes. The Association of International Pharmaceutical Manufacturers (AIPM) brings together more than 50 companies accounting for over 80% of global pharmaceutical production. AIPM’s code of practice bars member companies from giving healthcare workers personal items, cash, or gifts. Only modest medical items are allowed, such as anatomical models or atlases used to educate patients.
Payment transparency is a separate requirement: companies disclose sponsorship of events and payment for consulting services to doctors, and where a specialist does not consent to individual disclosure, the data is published in aggregate. The same principle underlies the European EFPIA disclosure code and the UK’s Disclosure UK scheme: a transfer of value (ToV) is recorded regardless of whether the recipient allowed their name to be published, and the public has access to at least the industry’s cumulative payout figure.
International practice sets concrete limits on meal spending at scientific events, to rule out hidden influence through excessive hospitality.
Table 3. Meal limits under international codes
| Code | Meal limit | Condition |
|---|---|---|
| ABPI (United Kingdom) | £75, excluding VAT and gratuities | An upper bound, applied only in exceptional cases |
| INFARMA (Poland) | 200 PLN gross per person | A secondary part of the event, not funded separately |
Venue requirements follow the same logic. Companies avoid luxury hotels and resorts in the high season unless a major international congress is being held there. INFARMA’s criteria, for example, call for at least six hours of substantive programming for a full-day event and at least three hours for a half-day event. Any entertainment element is kept out of the main program and funded separately from member companies’ contributions.
The ISO 37001 standard sets out an anti-bribery management system for companies operating in several jurisdictions at once. The model runs on a plan / do / check / act cycle and covers leadership’s anti-corruption policy, regular risk assessment in procurement and sales, gift and hospitality rules, staff training, a confidential channel for reporting violations, and internal investigations. Adopting the standard reduces the risk of direct losses from kickbacks and protects company leadership from liability under extraterritorial laws such as the US Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act.
Where the Risk Hides Deeper Than Gifts to Staff
Dealing with external partners, such as logistics operators, distributors, and agents, creates a different kind of risk. Under EAEU member states’ laws, a company can be held liable for the actions of its representative if that representative was acting in the company’s interest.
Auditing a logistics partner for compliance with Good Distribution Practice (GDP) now rests on Order No. 260n of the Russian Ministry of Health dated 29 April 2025, «On Approving the Rules for Storing Medicinal Products for Human Use» (hereinafter, Order No. 260n), and EAEU Council Decision No. 80. References to the earlier Order No. 646n, which still turn up often in outdated materials, are no longer valid: that order lost effect on 20 May 2025. A partner’s failure to maintain proper storage or transport conditions can expose the business owner to criminal risk, even where the owner had no direct part in the breach.
Partners that handle narcotic and psychotropic substances need a separate check: their right to carry out this activity is confirmed by a licence, which is worth verifying against the databases of the Ministry of Internal Affairs and the Ministry of Health rather than taking the counterparty’s word for it. Contracts with distributors and agents should include an anti-corruption clause giving the right to terminate the agreement if the partner is found to have engaged in bribery.
Special care is needed when drafting contracts in cases where a company representative, rather than the company itself, holds the marketing authorization (MA). A dispute with such a representative can end in losing the rights to the MA along with the termination of the contract. That is why counterparty due diligence (KYC) in the EAEU pharmaceutical market goes well beyond checking a company registry: it makes sense to request the beneficial ownership structure, the history of disputes with other principals, and standing within industry associations, even where no open beneficial-ownership register exists in the partner’s country. A partner’s ethical reputation deserves the same scrutiny as its price and delivery times.
What to Do
Build a three-tier gift system with amounts set for each country of operation. Green zone: ordinary gifts within 3,000 rubles in Russia, 10 MCI in Kazakhstan (43,250 KZT in 2026), or the standard limits in Belarus. Yellow zone: items that require sign-off from the compliance officer. Red zone: cash, gift cards, and paid leisure or entertainment.
Update contracts with distributors and agents. Add an anti-corruption clause with a unilateral termination right, require the partner to be able to show that its own decisions in dealings with officials and doctors have a legitimate basis, and reserve the company’s right to audit the partner’s records on request if a breach is suspected.
Check hospitality limits ahead of the coming conference season for each jurisdiction: £75 for events involving UK-based specialists, 200 PLN gross for Poland, and the local limit for EAEU countries. Set these figures down in corporate policy before the autumn events begin.
Verify the regulatory basis behind GDP audits of partners. Make sure internal audit checklists reference Order No. 260n and EEC Council Decision No. 80, not the superseded Order No. 646n.
Run a short training session for staff who deal with doctors and officials, covering how the reciprocity principle works. Set a rule of transparency: every gift is handed over openly and logged in the corporate register.
The regulatory gap between Russia, Kazakhstan, and Belarus will stay in place for a long time yet. AIPM and ISO 37001 standards, meanwhile, will keep tightening in line with international practice. Companies that are already turning gift and hospitality decisions into a formal system of limits and contract clauses gain more than protection from fines: they gain a reputational edge with partners and investors, for whom transparency in dealings with doctors and officials is becoming part of how they judge the company itself.
Regulatory basis:
1. Civil Code of the Russian Federation, Article 575, «Prohibition of Gift-Giving»
2. Criminal Code of the Russian Federation, Articles 290, 291, 291.2
3. Federal Law No. 323-FZ of 21 November 2011, «On the Fundamentals of Protecting the Health of Citizens in the Russian Federation,» Article 74 (as amended by Federal Law No. 150-FZ of 7 June 2025)
4. Civil Code of the Republic of Kazakhstan (Special Part), Article 509
5. Administrative Code of the Republic of Kazakhstan, Article 676
6. Law of the Republic of Belarus No. 305-Z of 15 July 2015, «On Combating Corruption»
7. Tax Code of the Republic of Belarus, Article 208, paragraph 22
8. Order of the Russian Ministry of Health No. 260n of 29 April 2025, «On Approving the Rules for Storing Medicinal Products for Human Use»
9. EAEU Council Decision No. 80 of 3 November 2016, «On Approving the Good Distribution Practice Rules of the Eurasian Economic Union»
10. Code of Good Practice of the Association of International Pharmaceutical Manufacturers (AIPM), 2025 edition
11. ISO 37001:2016, «Anti-bribery management systems»